Health
Pharma Firms Face Scrutiny Over Weight-Loss Drug Focus and Insulin Supply
Experts warn that the pharmaceutical industry's shift toward lucrative weight-loss drugs may jeopardize the availability of essential insulin for diabetes patients in lower-income nations.